A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis (Q33397410)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis |
scientific article |
Statements
1 reference
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis (English)
1 reference
Adam Cuker
1 reference
Alasdair J Coles
1 reference
Herman Sullivan
1 reference
Edward Fox
1 reference
Mark Goldberg
1 reference
Pedro Oyuela
1 reference
Annie Purvis
1 reference
Diana S Beardsley
1 reference
David H Margolin
1 reference
29 September 2011
1 reference
Identifiers
1 reference